Utilizing co-culture models, we found that LDHC expression in breast cancer cells likely promotes an immunosuppressive tumor microenvironment, impairing immune cell function through alterations in cytokine secretion and modulation of immune checkpoint expression. This evidence concerns the gene LDHC and breast cancer.